HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients. - Wikidata - awgldk - TriplyDB

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

http://www.wikidata.org/entity/Q34922069

about

Exosomes as mediators of neuroinflammation The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy.Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-a Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism Neurology and the Global HIV Epidemic.Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.Understanding the MIND phenotype: macrophage/microglia inflammation in neurocognitive disorders related to human immunodeficiency virus infection.Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy.Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women's Interagency HIV Study (WIHS).The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India.Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais.Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals.Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection.Frontline Science: CXCR7 mediates CD14(+)CD16(+) monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS.Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression.Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control.Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.Clinical Relevance of Total HIV DNA in Peripheral Blood Mononuclear Cell Compartments as a Biomarker of HIV-Associated Neurocognitive Disorders (HAND).Cognition, emotional health, and immunological markers in children with long-term nonprogressive HIV.Characterization of Cellular Immune Responses in Thai Individuals with and without HIV-Associated Neurocognitive Disorders.EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment.In Vitro Blood-Brain Barrier Modeling adapted for Peripheral Blood Mononuclear Cell Transmigration from HIV-Positive Patients for Clinical Research on Therapeutic Drug Intervention

P2860

Q26865141-7E87BCC4-15FC-431C-9375-945F13F9DC7B Q28066725-6E8E3A2E-E1BA-4ED6-B6FC-C3B012BF112F Q30250271-7D9FEE9D-E975-4017-8F4B-584FFEF26625 Q34221268-73A22A76-8DC8-47BB-965B-4FE9FED49584 Q34718135-7760BC13-FB45-48A5-9682-C91E3B1B92D6 Q35057044-6701CAF3-1180-4BC9-88D8-DD9F42C738DD Q35149362-58BFA748-1C8A-4A72-B343-111CB94983AE Q35154529-F1D1D3E4-760B-4428-8E79-4E16551D4C1B Q35220349-A0415888-39B5-40A5-931E-5FE8D02F2E1E Q35264787-4F987EF8-A451-436D-BF86-5C16639E7A47 Q35325801-685119A6-59D8-4EF0-8320-0038C5DE7ED1 Q35652578-3A473D17-74D0-4D0B-ACB4-3588CBFC651A Q35797131-CCB68A81-652A-4E27-9B3A-70D1D3A10C91 Q35814748-1BD3E209-69D1-4077-A9DE-DC388F0FA395 Q35837184-B87ACEF3-63BB-47AC-A933-2DD23DE3D6A1 Q35880399-0BBC9406-ABD8-4A2B-A6CE-09E8C0A5C3B9 Q35883236-BC98FC56-578B-4D6C-BED2-FE3AC105FDC7 Q36238501-6000E286-5F8B-4526-8D8F-E9B257DD8EE0 Q36250020-70B4C3BF-5DFD-4139-BAAD-4A4B1D2C135E Q36250205-01196259-B993-4321-A832-E413A7B1BAC8 Q36316590-F449C63B-2ABB-437D-B514-40634DEA4FE2 Q36463660-998DA6D1-8D63-43FF-8FAB-C50E8D3CD51D Q36957941-99BA13A1-9266-47B3-9524-3196FCD6E45E Q38247035-13560A17-199F-4B30-BD3D-0C7B3112A245 Q38433342-8DF36474-766A-42A6-99A3-F7C8573FC38B Q38654347-C4D200A4-94C0-4079-921A-105FDF6A088E Q38948215-B0D03DCB-A7A5-4D1C-AE04-DE291F3C8F98 Q40315607-A280124F-BF05-4035-9277-9CEA42003B14 Q40478716-27F9BA0A-EB9E-43A5-BA98-CB0010D7A38D Q40507828-BAEDF89C-F6B2-4780-87CB-D067B0AF8569 Q41716577-8A85AEBD-F71B-4020-92B9-6686D9444A9F Q42203691-2604E1D4-C097-4127-8A2E-03A6481C5EAE Q46531545-7AE08A44-0EFF-4189-9CA9-BAB49F72342D Q47558623-A71874B6-4CD3-46B8-AF7B-157E430BD15D Q54218501-C0195BDD-A8DD-40D6-B2F1-8B8D175781BD Q55255033-EAE76C37-C91C-4765-84DA-ADF54B6A5F7F Q58775726-6BC3AC15-19DD-46D3-9088-2693968C6E61

P2860

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

http://www.wikidata.org/entity/Q34922069

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@ast

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@en

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@nl

type

label

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@ast

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@en

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@nl

prefLabel

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@ast

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@en

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@nl

P1433

Q34922069-C5F2A248-BD22-43B3-B9CD-1900195D9DAE

P1476

Q34922069-0AF91904-404D-4FBB-A9C4-B0CD61820E7C

P2093

Q34922069-0A13321D-7040-42EA-9B5D-A32C57DFF3D1

Q34922069-1DA2AE93-BF75-4351-9D91-4FA8FCBB007D

Q34922069-273945BE-5B6E-4A1B-B59E-214C96777974

Q34922069-3706AA6F-A6EB-4BD4-9067-2004D9B28550

Q34922069-49283944-06B2-41E9-8CE6-B49DB020D56A

Q34922069-52E0CF12-0F19-4F04-A9EE-792D09DEC2C5

Q34922069-5A7BFB1D-889E-4AB5-91AB-6ACD349203EB

Q34922069-8255039A-6849-4191-B1B1-65BE610B18C9

Q34922069-93330A80-1B66-4B29-BC49-5613A7753043

Q34922069-A799695F-87C4-4A5A-8433-A21808CBB061

P2860

Q34922069-02AD51BA-B346-45AC-9820-32C4CB7E1940

Q34922069-2DFF469E-0FDD-4587-B43A-E77990B3DF83

Q34922069-31208164-81FE-43A0-A6BB-490D84C02438

Q34922069-3B0A6299-761F-4DE8-A792-D9BB85B3FB87

Q34922069-43A09234-E37A-41FA-A949-7264D6CD19A8

Q34922069-5B75474F-88C5-478B-896D-710F085F86D9

Q34922069-62C14CB7-7D24-4351-8961-9718BCCB64F7

Q34922069-711A7F0A-7777-4F20-816D-A9551FD821A7

Q34922069-8EB85E5F-83C0-4A65-BB7A-52D1C8A098D9

Q34922069-8EEEDB44-3953-45FA-AAAB-2B538C184110

P304

Q34922069-6BCF16DC-396D-40F9-B393-1B2C4576A12E

P31

Q34922069-32A60BC1-014B-432E-A5DF-14F571D7CA6C

P356

Q34922069-7508E0F3-C07C-4E0E-AA3E-ABE837F30440

P407

Q34922069-03160BF8-72BE-44E1-A2C3-B302CF24147A

P433

Q34922069-C13694FB-55A1-4D59-912C-BB0098E8BA62

P478

Q34922069-E695FAAA-11C8-489B-9349-913007D8490F

P50

Q34922069-3BA45B8C-5CED-4C11-9390-635FFD345FF6

P577

Q34922069-D5E960F7-69C7-4522-9D30-961363F13A26

P5875

Q34922069-A3F30F78-BD27-4170-8ACD-DF1E87FFC14F

P698

Q34922069-B0355FD7-5039-4675-AE75-6E62BB3A081B

P932

Q34922069-3C841E45-F0B5-4CC2-9803-9E795B65E3A2

P356

JOURNAL.PONE.0070164

P1433

P1476

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

@en

P2093

Alexandra Schuetz

http://www.w3.org/2001/XMLSchema#string

Bonnie M Slike

http://www.w3.org/2001/XMLSchema#string

Bruce Shiramizu

http://www.w3.org/2001/XMLSchema#string

Cecilia Shikuma

http://www.w3.org/2001/XMLSchema#string

Chin-Yuan Liang

http://www.w3.org/2001/XMLSchema#string

David B Clifford

http://www.w3.org/2001/XMLSchema#string

James L K Fletcher

http://www.w3.org/2001/XMLSchema#string

Mary A Marovich

http://www.w3.org/2001/XMLSchema#string

Melissa Agsalda

http://www.w3.org/2001/XMLSchema#string

Napapon Sailasuta

http://www.w3.org/2001/XMLSchema#string

P2860

The neuropathogenesis of AIDS

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Theory and application of array coils in MR spectroscopy.

HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications.

Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage

Circulating proviral HIV DNA and HIV-associated dementia.

Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.

Updated research nosology for HIV-associated neurocognitive disorders

Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.

HIV proviral DNA associated with decreased neuropsychological function

P304

e70164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0070164

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Jintanat Ananworanich

P577

2013-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259758831

http://www.w3.org/2001/XMLSchema#string

P698

23936155

http://www.w3.org/2001/XMLSchema#string

P932

3729685

http://www.w3.org/2001/XMLSchema#string